HIGHLIGHTS
- who: Soraya Ahmadi-Balootaki from the (UNIVERSITY) have published the article: Targeting the MALAT1 gene with the CRISPR/Cas9 technique in prostate cancer, in the Journal: (JOURNAL)
- what: This study aims to evaluate the elimination of changes of MALAT1 in DU-145 cells and its effects on proliferation, migration, and apoptosis. This study has received approval from the research ethics committee of the college (IR.IAU.M.REC.1399.010). In accordance with the above study, the study showed that research on lncRNAs can contribute to cancer prognosis .
- how: The multivariate results showed . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.